Q3 Technologies is a large diversified technology company offering technology consulting and outsourcing software products and applications development services to the global IT industry, will be exhibiting at the OutsourceWorld 2009 that is going to be held in New York (USA) from 11^th Nov’09 to 12^th Nov’09. This will be Q3 Technologies’ second participation at the OutsourceWorld.

OutsourceWorld is a pure-play business trade platform for executives who have a need to outsource business services. OutsourceWorld is the premier industry event, which focuses on sourcing and globalization and provides an excellent platform for software companies to reach out to the global market. OutsourceWorld is an event crafted for business leaders charged with strengthening their organization, improving competitiveness and increasing profit margins in an economy that has undergone significant structural changes.

At Global Sourcing Forum and Expo (GSFE), participating companies would get an opportunity to learn from influential leaders, executives, and practitioners who are leveraging global services to tackle economic challenges and to strategically grow their business.

This event is unique as it brings academics, thought leaders, sourcing executives and global suppliers from over 25 countries, all in just 2 days under one roof to discuss debate and learn about the challenges and opportunities posed by changes in their industry. This event has a great significance for medium and large-sized companies that are increasingly adopting global sourcing and offshoring as a competitive tool.

Exhibitors like Q3 technologies use this platform as a launch pad for their latest products. This is a 2 day IT event that will have the largest presence of  IT and ITES (IT enabled companies) companies with their innovative IT products & services. In addition, Q3 will explore established and emerging client destinations and follow best practices to successfully source, manage and deliver global services.

At OutsourceWorld 2009, Q3 technologies would be showcasing its expertise across a gamut of innovative solutions built around cutting-edge technologies in Microsoft .Net, Java and other open source platforms.

The next few days will see hectic activities in the company’s development center (India) and overseas offices as preparations are made for OutsourceWorld 2009. Q3 Technologies will also be exhibiting at the ESC IT Meet to be held on 9^th Nov’09 at Bogota, Colombia. This meet will have presence of  software companies with their innovative IT products & services.

With the dawn of technology into the field of Life Science has changed the drug designing process in the pharmaceutical industry. This marriage of Life Science and Information technology has decreased the total time for a “New Drug” to be in the market. The goal of modern computer-aided drug design (CADD) is to make use of statistical and molecular modeling techniques to aid in the design or discovery of new lead structures.

Life Science is the study at a bio-molecular (Protein and DNA) level. Visualizing the interactions between bio-molecules (or drug-protein interactions) has greatly helped in understanding the chemistry involved so as to develop a better ‘Drug’ molecule. Life Science projects categorized into two main fields Bioinformatics and Cheminformatics.

Bioinformatics includes the study of the proteins and DNA at a sequence and structural level. The ultimate goal of the field is to enable the discovery of new biological insights as well as to create a global perspective from which unifying principles in biology can be discerned.

Cheminformatics is the application of informatics tools to solve discovery chemistry problems, from library shaping to ADME-Tox prediction via virtual screening; computational chemistry is an integral component of hit and lead generation. These tools address the need to facilitate, store, and explore the chemical and biological data that is the key success to drug discovery programs.

Silico methods can help in identifying drug targets via bioinformatics tools. They can also be used to analyze the target structures for possible binding/ active sites, generate candidate molecules, check for their drug likeness, dock these molecules with the target, rank them according to their binding affinities, further optimize the molecules to improve binding characteristics. The use of computers and computational methods permeates all aspects of drug discovery and forms the core of structure-based drug design.

Q3 technologies is involved in the development of such products that have high visibility in pharmaceutical industry. Q3 technologies Life Science team works on the improvement of the quality and usability of the Bioinformatics & Cheminformatics product lines.